175 related articles for article (PubMed ID: 31621118)
1. Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation.
Liu D; Wu K; Yang Y; Zhu D; Zhang C; Zhao S
Mol Carcinog; 2020 Jan; 59(1):32-44. PubMed ID: 31621118
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer.
Chen Z; Tang W; Ye W; Song L; Chen Z
Cell Cycle; 2022 Aug; 21(16):1710-1725. PubMed ID: 35503407
[TBL] [Abstract][Full Text] [Related]
3. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
[TBL] [Abstract][Full Text] [Related]
4. ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis.
Xu W; Wang B; Cai Y; Chen J; Lv X; Guo C; Yuan C
Curr Pharm Des; 2021; 27(23):2722-2727. PubMed ID: 33823762
[TBL] [Abstract][Full Text] [Related]
5. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.
Xie S; Yu X; Li Y; Ma H; Fan S; Chen W; Pan G; Wang W; Zhang H; Li J; Lin Z
Mol Ther; 2018 Dec; 26(12):2766-2778. PubMed ID: 30217729
[TBL] [Abstract][Full Text] [Related]
7. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.
Yao J; Zhou B; Zhang J; Geng P; Liu K; Zhu Y; Zhu W
Tumour Biol; 2014 Aug; 35(8):7935-44. PubMed ID: 24833086
[TBL] [Abstract][Full Text] [Related]
8. Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p.
Guo Q; Ni P; Dai Y; Hu J; Yao Y
J Interferon Cytokine Res; 2021 Feb; 41(2):60-71. PubMed ID: 33621133
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
10. [Overexpression of the long non-coding RNA ADAMTS9-AS2 suppresses colorectal cancer proliferation and metastasis].
Bu X; Qin A; Luo Z; Hu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):741-748. PubMed ID: 31413211
[TBL] [Abstract][Full Text] [Related]
11.
Shen FF; Zhang F; Yang HJ; Li JK; Su JF; Yu PT; Zhou FY; Che GW
Biomark Med; 2020 Oct; 14(15):1415-1426. PubMed ID: 32892630
[No Abstract] [Full Text] [Related]
12. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation.
Li N; Zhao Z; Miao F; Cai S; Liu P; Yu Y; Wang B
Cancer Gene Ther; 2021 May; 28(5):471-485. PubMed ID: 33199829
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ADAMTS9-AS2 regulates periodontal ligament cell migration under mechanical compression via ADAMTS9/fibronectin.
Yu Q; Guo K; Yang Y; Liu H; Huang Y; Li W
J Periodontal Res; 2024 Feb; 59(1):174-186. PubMed ID: 37957805
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine-mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B/let-7/MYCN signaling.
Liu Y; Zhang J; Cao F; Dong X; Li J; Cao Y; Li Z; Guo Y; Yan J; Liu Y; Zhao Q
JCI Insight; 2023 Nov; 8(22):. PubMed ID: 37991019
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
Wang A; Jin C; Li H; Qin Q; Li L
Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
[TBL] [Abstract][Full Text] [Related]
19. M6A Promotes Colorectal Cancer Progression via Regulating the miR-27a-3p/BTG2 Pathway.
Liu W; Zhang Z; Luo X; Qian K; Huang B; Deng J; Yang C
J Oncol; 2023; 2023():7097909. PubMed ID: 36816363
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor RUNX1T1.
Sun T; Yang P; Gao Y
Exp Physiol; 2020 Jan; 105(1):75-87. PubMed ID: 31645082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]